Does SOMATROPIN Cause Neoplasm malignant? 129 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 129 reports of Neoplasm malignant have been filed in association with SOMATROPIN (Nutropin AQ NuSpin 10). This represents 0.2% of all adverse event reports for SOMATROPIN.
129
Reports of Neoplasm malignant with SOMATROPIN
0.2%
of all SOMATROPIN reports
4
Deaths
13
Hospitalizations
How Dangerous Is Neoplasm malignant From SOMATROPIN?
Of the 129 reports, 4 (3.1%) resulted in death, 13 (10.1%) required hospitalization, and 1 (0.8%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SOMATROPIN. However, 129 reports have been filed with the FAERS database.
What Other Side Effects Does SOMATROPIN Cause?
Drug dose omission by device (15,921)
Device leakage (9,113)
Device breakage (7,761)
Device mechanical issue (6,411)
Device information output issue (5,220)
Device issue (5,131)
Wrong technique in device usage process (4,746)
Injection site pain (4,009)
Poor quality device used (3,162)
Device use error (2,801)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which SOMATROPIN Alternatives Have Lower Neoplasm malignant Risk?
SOMATROPIN vs SONIDEGIB
SOMATROPIN vs SORAFENIB
SOMATROPIN vs SORGHUM HALEPENSE POLLEN
SOMATROPIN vs SOTAGLIFLOZIN
SOMATROPIN vs SOTALOL